FACTS ABOUT HEMGENIX REVEALED

Variety of qualified clients: CDEC talked over the uncertainty in the volume of patients with moderately severe to severe hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific authorities consulted by CADTH indicated that some sufferers that are categorized as possessing gentle or moderate disease might have a serious bleeding p